101 related articles for article (PubMed ID: 6975993)
1. [Prognostic value of T-cell markers in juvenile acute lymphatic leukemia].
Plüss HJ; Joller PW; Hitzig WH
Schweiz Med Wochenschr; 1981 Oct; 111(41):1527-9. PubMed ID: 6975993
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factor analysis in acute lymphocytic leukemia of childhood.
Plüss HJ
Helv Paediatr Acta; 1987 Oct; 42(2-3):197-247. PubMed ID: 3480281
[TBL] [Abstract][Full Text] [Related]
3. [The prognostic value of immunologic markers in juvenile acute lymphatic leukemias and non-Hodgkin lymphomas].
Plüss HJ; Joller PW; Hitzig WH; Jakob M
Schweiz Med Wochenschr; 1979 Sep; 109(37):1379-82. PubMed ID: 314664
[TBL] [Abstract][Full Text] [Related]
4. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.
Greaves MF; Janossy G; Peto J; Kay H
Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165
[TBL] [Abstract][Full Text] [Related]
5. Lack of influence of T-cell marker and importance of mediastinal mass on the prognosis of acute lymphocytic leukemias of childhood.
Hann HW; Lustbader ED; Evans AE; Toledano SR; Lillie PD; Jasko LB
J Natl Cancer Inst; 1981 Feb; 66(2):285-90. PubMed ID: 6969813
[TBL] [Abstract][Full Text] [Related]
6. A clinical perspective on cell markers in acute lymphocytic leukemia.
Bowman WP; Melvin SL; Aur RJ; Mauer AM
Cancer Res; 1981 Nov; 41(11 Pt 2):4794-801. PubMed ID: 6975162
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
8. Peanut agglutinin, a marker for T-cell acute lymphoblastic leukemia with a good prognosis.
Veerman AJ; Hogeman PH; Huismans DR; Van Zantwijk CH; Bezemer PD
Cancer Res; 1985 Apr; 45(4):1890-3. PubMed ID: 3872169
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of early treatment response in children with acute myeloid leukemia].
Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
[TBL] [Abstract][Full Text] [Related]
10. Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia.
Dow LW; Borella L; Sen L; Aur RJ; George SL; Mauer AM; Simone JV
Blood; 1977 Oct; 50(4):671-82. PubMed ID: 268981
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
12. Is T-cell acute lymphoblastic leukemia still a high risk leukemia in children?
Cáp J; Foltinová A; Kaiserová E; Babusíková O; Jamárik M; Jasenková M
Neoplasma; 1998; 45(3):135-9. PubMed ID: 9717524
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostik significance of cell membrane markers in childhood ALL (author's transl)].
Haas RJ; Netzel B; Janka GE; Rodt H; Thiel E; Thierfelder S
Klin Padiatr; 1978 Sep; 190(5):446-52. PubMed ID: 309025
[TBL] [Abstract][Full Text] [Related]
15. The use of leukocyte acid phosphatase in the diagnosis of malignant disease. Case report and review of literature.
Morse EE; Quinn J; Altman A; Talaizedeh M; Brassel J; Taubman S
Ann Clin Lab Sci; 1980; 10(2):143-8. PubMed ID: 6966904
[TBL] [Abstract][Full Text] [Related]
16. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte markers in childhood ALL: the lack of correlation with prognosis.
Cristo Morón E; Révész T; Schuler D
Acta Paediatr Acad Sci Hung; 1982; 23(2):171-7. PubMed ID: 6982589
[TBL] [Abstract][Full Text] [Related]
18. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
20. CALLA-negative, TdT- and CD7-positive acute lymphoblastic leukemia: a phenotype associated with poor prognosis.
De Rossi G; Aloe Spiriti MA; Cafolla A; Gastaldi R; Lo Coco F; Lopez M; Luciani M; Pasqualetti D; Testi AM; Mandelli F
Diagn Clin Immunol; 1987; 5(3):140-3. PubMed ID: 3319281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
